Immediate Post-TURBT Mitomycin C Reduces NMIBC Recurrence Risk
FG_AUTHORS: Renal and Urology News
HTTP/1.1 200 OK Cache-Control: private Content-Type: text/html; charset=utf-8 Date: Wed, 16 Aug 2017 11:16:13 GMT From: VM-Web3-RUN Server: Microsoft-IIS/8.5 X-AspNet-Version: 4.0.30319 X-AspNetMvc-Version: 4.0 X-Powered-By: ASP.NET Content-Length: 135102 Connection: keep-alive
Immediate Post-TURBT Mitomycin C Reduces NMIBC Recurrence Risk - Renal and Urology NewsRead more http://www.renalandurologynews.com/nmibc-recurrence-risk-reduced-intravesical-mitomycin-c-within-24-hours-turbt/article/682019/